Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
25. April 2024 08:05 ET
|
Shareholder Capital LLC
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
SHAREHOLDER ALERT: Barr Law Group Investigating VNDA, VLDR, RIDE, and ABT; Shareholders are Encouraged to Contact the Firm
17. März 2021 13:56 ET
|
Barr Law Group
SAN DIEGO, March 17, 2021 (GLOBE NEWSWIRE) -- National law firm Barr Law Group is investigating the actions of the officers and board of directors of Vanda Pharmaceuticals Inc., Velodyne Lidar,...
FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
25. April 2019 10:00 ET
|
Schall Law
LOS ANGELES, April 25, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Vanda Pharmaceuticals Inc....
A Securities Class Action Has Been Filed Against Vanda; Block & Leviton LLP Encourages Shareholders to Contact the Firm
17. April 2019 16:11 ET
|
Block & Leviton LLP
BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, informs investors that there has been a class...
Hagens Berman Reminds Vanda Pharmaceuticals (NASDAQ: VNDA) Investors of the April 26, 2019 Lead Plaintiff Deadline and Unsealed Government Lawsuit
28. März 2019 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 28, 2019 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) of the April 26, 2019 Lead Plaintiff deadline in the...
Block & Leviton LLP Reminds Shareholders of Important Deadlines: AMRN, ASTE, INGN, VNDA
26. März 2019 15:38 ET
|
Block & Leviton LLP
BOSTON, March 26, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines...
VNDA ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA
12. März 2019 16:44 ET
|
Zhang Investor Law P.C.
NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Vanda Pharmaceuticals Inc. (NASDAQ:...
IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
05. März 2019 14:52 ET
|
Schall Law
LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Vanda Pharmaceuticals Inc....
ONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
14. Februar 2019 15:00 ET
|
Schall Law
LOS ANGELES, Feb. 14, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vanda...
Vanda Pharmaceuticals Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws
11. Februar 2019 10:49 ET
|
Block & Leviton LLP
BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Vanda Pharmaceuticals...